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Background: The prevalence of chemsex and sexualized substance use is increasing
in several European countries, particularly among men who have sex with men. In this
subgroup, illegal substance use is associated with increased sexual risk behavior, which
can result in severe physical and psychological impairments. The present study examined
the incidence and prevalence of chemsex in German-speaking countries.
Methods: To further describe the high-risk group of Chemsex users, participants (N
= 429) were asked about their psychotropic substance use, sexual and health-related
behavior, health status, and socio-demographic information by using an online
questionnaire. Whether Chemsex has negative effects on well-being was measured with
the WHO well-being index. Of additional interest was how informed Chemsex users are
about the topic and what needs are placed on the practitioners. The online questionnaire
consisted of 105 items, and data was collected fromMarch to May 2019. Thousand forty
seven datasets were saved with a dropout rate of 59%, 123 completed questionnaires
fulfilled the criteria for chemsex users (n =123).
Results: There were no significant differences in well-being between chemsex users and
non-users. All participants protected themselves against sexually transmitted diseases
irregularly or not at all. The majority of chemsex users reported intermittently using illegal
substances (ketamine, methamphetamine, mephedrone, γ-butyrolactone/γ-hydroxy
butyric acid). They viewed their sexual and substance use behavior as problematic, but
few showed motivation for behavior change. Chemsex users clearly expressed a need
for more information and advice centers.
Conclusion: The results provide information on chemsex users that can be used for the
future development of a therapy manual and thus contribute to improving health care for
this group. The prevalence of chemsex is increasing and urgently needs more research
to protect clients from health impairments and stigmatization.
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INTRODUCTION
The use of mind-altering substances is a well-known social
phenomenon, and population-wide substance use remains a
matter of concern. Approximately 269 million adults worldwide
used illicit drugs at least once in 2018 (1), with 29% of those aged
15–64 estimated to be from the European Union (2).
In the 15 to 64 age group, problematic use is described in this
context; of the 11.3 million i. v. users, about half were infected
with hepatitis C and about 12.6% with HIV (3). According to the
United Nations Office on Drugs and Crime, around 35 million
people suffer from health disorders caused by drug use and
require treatment services (1).
Two specific types of substance use are chemsex and sexual
motivated substance use, whereby the former describes the extent
of andmotivation for substance usemore explicitly than the latter
(4). The literature differentiates between the 2 terms because
of the higher risk potential of chemsex (5). Chemsex is used
to initiate sexual acts and increase or disinhibit the pleasure,
duration, and intensity of the sexual experience (4, 6, 7). It is also
referred to as “party and play” (8, 9).
Chemsex users take one or more illegal psychoactive
substances to influence sexual perception and behavior and
enable long-lasting sex sessions, sometimes over several days,
or sex with several partners simultaneously (5, 6, 8, 10,
11). Four illegal psychoactive substances are mainly used for
chemsex: methamphetamine, mephedrone, ketamine and γ-
butyrolactone (GBL)/γ-hydroxin butyric acid (GHB) (4, 9).
These substances, also referred to as the “4 chems” (5, 9),
are mostly consumed orally or nasally, although intravenous
use does occur (known as slam sex) (12). Chemsex substances
differ from the “party drugs” used for recreation, although
these recreational activities may include sexual activities; the
preferred party drugs include ecstasy, amphetamines, and
cocaine (13–15). The four chems have an increased addiction
potential and can also cause lasting damage. Ketamine use
can lead to near-death experiences and trigger drug-induced
psychosis (16). Overdoses of mephedrone may cause thought
disorders, anxiety states, panic attacks, acoustic hallucinations,
palpitations, nausea, and vomiting (17–19). The negative effects
of methamphetamine include motor restlessness, aggressiveness,
panic attacks, concentration disorders, and long-term effects on
the brain. GHB/GBL overdose can lead to a loss of consciousness
or even respiratory depression (20–22). In addition, there is
the danger of unconscious mixed use, which is caused by
contaminated substances. For example, the case report by Pichini
et al. described how two people consciously used GHB in a
sexual context, but the substance was unknowingly mixed with
sildenafil, which in turn led to physical discomfort and even
a visit to the emergency room (23). Besides these negative
effects of drug use among chemsex users, other problematic
aspects include criminalization through illegal procurement of
the substances and the risk of social decline (20).
Generally, substance use is higher among lesbian, gay,
bisexual, and transgender (LGBTQ) people than among purely
heterosexual people (24), partly because of sexual substance use
(25). Chemsex occurs predominantly among men who have sex
with men (MSM) (6). Peer groups have been shown to have
a stronger influence on sexual behavior than family members
(26), particularly in the MSM community (27). In a qualitative
study on the experiences of 30 MSM, the interviewees reported
that drug use and in particular chemsex is now perceived as
being ubiquitous in the MSM community (7). Often, sex dates
are arranged through mobile dating apps such as Grindr©.
Before they meet, the parties not only arrange the location
but also exchange information including the type of substance
use, HIV status, and number of participants. This virtual
communication allows like-minded people to meet each other
without having to visit bars, clubs, or similar locations and allows
them to meet their sexual needs more quickly and effectively
(5, 28).
Chemsex is associated with increased health risk behavior,
which can lead to increased rates of sexually transmitted diseases
(STDs) and even to death from drug intoxication (11, 28–30).
MSM are considered to be one of the main risk groups for new
infections with STDs such as HIV (31–34). Safer sex practices
are often neglected during (group) sex sessions with substance
use, and needles may also be shared (35). The disinhibition
resulting from substance use means that chemsex users often
consume more psychoactive substances than planned, and a lack
of knowledge about the dosage can lead to severe intoxications
and even to fatal overdoses (12). The European MSM Internet
Survey, the first study to examine the extent and spread of
chemsex in Germany (35, 36), found a significant association
between psychotropic substance use and risky sexual behavior
(37). For example, 26% of the study participants in Germany
(n = 54,387) stated that they had unprotected anal intercourse
with men. The study also showed a positive association between
positive HIV status and increased risky health behavior, such as
promiscuity and unprotected sexual intercourse (35).
In spring 2018, the Ludwig-Maximilians-University Hospital
Munich, department of psychiatry opened a special outpatient
clinic to provide support to chemsex users, and the clinic is seeing
increasing numbers of people. The counseling and treatment of
people with sexual motivated substance use is problematicmainly
because of the combination of harmful use of psychotropic
substances and sexual risk behavior. Compared with data
on other psychiatric phenomena, data on the prevalence of
chemsex and characteristics of chemsex users is still lacking
(6), especially in German-speaking countries. Furthermore to
our knowledge, no standardized guidelines or therapy programs
exists. Therefore, the present study aimed to better define the
group of people that engages in chemsex, obtain data on their use
of chemsex and needs for advice and information, and assess their
well-being. The specific research questions were as follows:
A. Can demographic variables be used to identify a high-risk
group for chemsex?
B. What are the main characteristics of the sexual and health
behavior and frequency of use of psychotropic substances, in
particular the 4 chems?
C. Does chemsex affect the well-being of users?
D. What do users know and need from clinics on the topic
of chemsex?
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This project has been approved by the ethical committee by the
Ludwig-Maximilians-University Hospital Munich, department
of psychiatry and was registered bay the number: 18–819 KB.
MATERIALS AND METHODS
Recruitment and Sample
Participation in this field study was limited to people in
German-speaking countries. Persons of all gender and legal
age and who had functioning online access could participate
in the survey. Due to the exploratory character of this study
and the aspects that chemsex users belong to a group that
is difficult to identify and locate, the method of snowball
sampling was chosen for statistical purposes. Participants were
mainly recruited from the LGBTQ community. They were
recruited by flyers in the psychiatric outpatient clinic at the
Ludwig-Maximilians-University Hospital Munich, department
of psychiatry, at regional scientific congresses, and nationwide
via AIDS and addiction advice centers, LGBTQ contact and
advice centers, specialist hospitals for the treatment of addiction
disorders, and relevant bars in large German cities. People on
the email distribution list of the Ludwig Maximilian University
Munich were also invited to participate. The study was also
publicized on social media such as Planet Romeo (a dating
app for homosexual and bisexual men), the homepage of the
chemsex outpatient Ludwig-Maximilians-University Hospital
Munich, department of psychiatry, the Facebook page of the
interdisciplinary HIV Center IZAR of the Technical University
Munich, and via the personal Facebook and Instagram accounts
of the authors. Articles about the study in 2 digital lifestyle
magazines for homosexual and bisexual men, Boner Magazine
and GLEICHLAUT, also encouraged readers to participate.
Assessment
Participants anonymously completed an online questionnaire
between March 2 and May 31, 2019. The questionnaire inquired
about sociodemographics, sexual and health behavior, frequency
of psychotropic substance use, and well-being. It included a list of
legal and illegal controlled substances in Germany that was based
on the medical guidelines on health care for methamphetamine-
related disorders (38). The order, content, and number of items
in the questionnaire are shown in Table 1. At the end of
the questionnaire, all participants were able to leave personal
comments as free text.
To assess substance use, participants were asked about their
use of 23 psychotropic substances in the past 12 months (options:
never, about once every 3 months, about once a month, about
once a week, several times a week, daily). Sexual behavior was
assessed on a 7-point Likert scale ranging from 1 (strongly
disagree) to 7 (strongly agree). Participants used the scale to
rate how strongly they agreed that in the past 12 months
they had had sex while under the influence of substances, had
participated in group sex, or had attended private sex parties.
They were also asked how and where they had found sexual
partners (eg, “I use online sites to arrange sex, for example,
PlanetRomeo, Scruff, Grindr), who they preferred having sex
with (e.g., men, women, people they know, or sex workers), and
TABLE 1 | Content of the questionnaire.
Order Content Number of
items
1. Age, sex, sexual orientation 3
2. WHO Well-Being Index (WHO-5) 5
3. Relationship Scales Questionnaire (RSQ) 30
4. List of psychotropic substances 23
5. Number of sexual partners in the past 12
months and sexual behavior
14
6. Level of sexual activity, chemsex, and attitude
toward chemsex
6
7. Length of time having sex without the influence
of alcohol or psychotropic substances
2
8. Sexual activity under the influence of alcohol 1
9. Protective behavior with respect to sexually
transmitted diseases
7
10. Health status with respect to sexually
transmitted diseases
3




13. Seriousness about answering the online
questionnaire
1
whether and how often their sexual behavior was influenced
by illegal substances. Additional questions inquired whether
participants saw themselves as chemsex users, viewed their own
chemsex behavior as problematic and wanted to change their
behavior. The topic of safer sex practices was also assessed with
a 7-point Likert scale ranging from 1 (strongly disagree) to 7
(strongly agree); questions concerned the use of condoms, drugs
for HIV pre- and post-exposure prophylaxis, and hepatitis A and
B immunization status. Participants were also asked to provide
information as free text about safer sex practices not included in
the list and to specify whether they used any safer sex practices
at all. We were also interested to find out whether participants
took measures to protect themselves from STDs depending on
whether they were having sex inside or outside a partnership.
Study participants were asked when they last had sex while
not under the influence of alcohol or illegal substances (response
options: in the past week, month, 3 months, 6 months, 12
months, and longer than 12 months). They were also asked
whether they drank alcohol before and during sex, which was
assessed on a 7-point Likert scale ranging from 1 (never) to 7
(always). To assess participant health status, the questionnaire
asked about current or past STDs and the time of the last test for
such diseases. Participants were also asked about their knowledge
of contact points and advice centers and about current and past
psychotherapy and psychiatric treatment. When responding to
the questions, participants were asked to consider the past 12
months because the study aimed to obtain an overview of the
current epidemiology of chemsex.
The participant’s current level of well-being was assessed with
theWHO-5 (39). This scale is a brief psychometric questionnaire
that uses five items to inquire about subjective well-being in the
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past 2 weeks (40). The scale has good reliability (Cronbach‘s
alpha = 0.92). A sum score of 0 to 13 indicates a low or
negative well-being.
Statistical Analysis
Data were analyzed with R, version 3.3.1 (June 21, 2016).
Participants were categorized as chemsex users and non-users on
the basis of their response on a 7-point Likert scale ranging from
1 (strongly disagree) to 7 (strongly agree) to the question whether
in the past 12 months they had used illegal controlled substances
to influence their sexual behavior. Participants who responded
with “strongly disagree” on the Likert scale were categorized as
non-users; all other participants were categorized as chemsex
users, the cut-off score was 2.
Data were tested for normal distribution with the Shapiro-
Wilk test (P < 0.05) and for homogeneity of variance with the
Levene test (P =.29). A t test was used to calculate whether
differences existed in the mean well-being of chemsex users
and non-users.
RESULTS
At the end of data collection, 1,047 data records were available.
The first screening showed that 618 participants did not complete
the questionnaire, so 59% their data could not be used for
statistical hypothesis testing. Among the remaining 429 data sets
that were suitable for further analysis, 123 were completed by
participants who stated that they had had sex under the influence
of illegal substances in the past 12 months [mean (SD) = 5.87
(1.69)], Figure 1 shows the frequency distribution for this item.
Themean (SD) age of all participants was 35.00 (13.01) years; and
of the chemsex users, 42.97 (11.66) years.
Sociodemographic Characteristics
Most of the participants described themselves asmale, and almost
half belonged to theMSM group. Themajority of the sample were
living in a partnership, had a college degree and were employed.
There were no difference when using the t test according to
the WHO-5 between the chemsex users and non-users, that is, it
did not indicate negative well-being in either group (P = 0.58).
The mean (SD) well-being score was 17.72 (4.65; median, 18;
range, 25) in the group of chemsex users (n = 123) and 17.98
in the group of non-users (4.13; median, 19; range, 25). Thus,
both groups were above the cut-off score of 13 (see 2.2 above).
A Cohen’s d of 0.59 resulted in an effect strength of 0.030.
Among the chemsex users, 93% described themselves as male
and 7% as female; 1 person in the group of chemsex users
described themselves as transsexual. The majority of chemsex
users described themselves as gay (72%), followed by bisexual
(21%) and heterosexual (7%). Regarding partnerships, 40% stated
that they were living with a partner, 15% were married, 40%
were single, and 6% were in other types of partnerships (e.g.,
open relationship). Almost half of the chemsex users (46%) had
a college degree, and 41% were employees. More than half (57%)
had a monthly net income between e1,000 and e3,500. Table 2
shows the sociodemographic characteristics of the participants.












Male 64% 93 53%
Female 35% 7 46%
Transsexual 1% 0 1%
Intersexual 0% 0 0%
Sexual orientation
Heterosexual 40% 7% 54%
Gay 40% 72% 27%
Lesbian 1% 0% 1%
Bisexual 19% 21% 18%
Partnership
With a partner 47% 40% 50%
Married 12% 15% 11%
Single 36% 40% 35%
Other 4% 6% 4%
Highest educational level
No school diploma - 0% 0%
School diploma after grade 9 or
10
4% 7% 3%




College degree 46% 46% 46%
PhD 6% 10% 5%
Employment status
Student at school or
college/apprentice
33% 8% 43%
Employee 32% 41% 29%
Senior staff 8% 9% 8%
Middle management 6% 11% 4%
Upper/top management 3% 7% 2%
Self-employed 10% 14% 8%
Retired 4% 6% 3%
Not currently employed 1% 2% 0%
Other 3% 2% 3%
Monthly net income
<e1,000 28% 10% 34%
e1,000–e2,000 28% 29% 22%
e2,000–e3,500 24% 28% 25%
e3,500–e5,000 26% 19% 8%
e5,000–e6,500 11% 4% 3%
Over e6,500 4% 9% 3%
State benefits 4% 1% 5%
Substance Use in the Group of Chemsex
Users
Among the chemsex users (n= 123), 71% had not used ketamine
in the past 12 months, but 14% had used about once every 3
months; 7%, about once a month; and 3% about once a week.
Frontiers in Psychiatry | www.frontiersin.org 4 May 2021 | Volume 12 | Article 690242
Rosenberger et al. “Let’s Talk About Chemsex”
FIGURE 1 | Frequency distribution of the item: “within the last 12 months I had sex under the influence of drugs”.
FIGURE 2 | Use of the 4 chems in the group of chemsex users (n = 123) in the past 12 month.
None of the chemsex users used ketamine several times a week or
daily, and 6% of chemsex users did not provide any information.
Regarding methamphetamine, 76% had not used it in the past
12 months, but 9% had used it about once every 3 months; 7%,
about once a month; 2%, several times a week; and 1%, daily.
Information on methamphetamine use was missing for 4% of the
chemsex users. Mephedrone had not been used in the past 12
months by 71% of the chemsex users, but 14% had used it about
once every 3 months; 7%, about once a month; and 3%, about
once a week. One person used mephedrone several times a week,
and 6% did not provide any information. GHB/GBL had not been
used in the past 12 months by 58% of the group of chemsex
users, but 22% had used it about once every 3 months during
this period, 9% about once a month, 4% about once a week, 4%
several times a week, and 3% did not provide any information.
The current intoxication when answering the questionnaire was
not recorded. Use of the 4 chems by the chemsex users is shown
in Figure 2.
Sexual and Health Behavior in the Group of
Chemsex Users
In the past 12 months, 71% [mean (SD) = 4.71 (2.79)] of
the chemsex users had sex with more than one person at the
same time, and the mean (SD) number of sexual partners in
the past 12 months was 24.59 (33.49) (median = 12; range, 0–
240). Most people in the group of chemsex users [92%; mean
(SD) = 5.70 (1.95)] used web portals such as Grindr or Planet
Romeo to arrange sex, and 60% [mean (SD)= 3.46 (2.49)] visited
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FIGURE 3 | Sexual behavior.
FIGURE 4 | Use of condoms, pre-exposure HIV prophylaxis (PrEP), and post-exposure HIV prophylaxis (PEP).
known bars, such as dark rooms or swinger clubs, to find sexual
contacts. Just over half of chemsex users [55%; mean (SD), 3.16
(2.41)] stated that they had participated in private sex parties.
An overview of sexual behavior in the past 12 months is shown
in Figure 3.
Regarding sexual behavior with respect to STDs, 31% [mean
(SD) = 3.38 (2.26)] of the chemsex users did not use a condom
during sex, 66% [mean (SD) = 2.44 (2.24)] did not take pre-
exposure drugs for HIV prophylaxis, and 85% [mean (SD)= 1.37
(1.23)] did not take post-exposure drugs for HIV prophylaxis
(Figure 4). Figure 4 shows that the majority of the chemsex users
did not take any protective measures against STDs: 17% stated
that they always use condoms during sex; 31%, that they always
use PrEP for HIV prophylaxis; and 7%, that they always use
post-exposure HIV prophylaxis. Twenty of the chemsex users
stated that they had HIV; information on the prevalence of
other STDs is shown in Figure 5. Almost half of the chemsex
users (46%) stated that they had been tested for STDs in the
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FIGURE 5 | Current and past sexually transmitted diseases among chemsex users.
past 3 months, and 10% stated that they had never been tested
for STDs.
Need for Advice, Level of Insight, and
Desire for Change Among the Chemsex
Users
Just over half (58%) of the chemsex users stated that they were
not aware of any contact or advice centers focusing on sexual
motivated substance use, and 45% stated that they did not know
of any advice center in their immediate vicinity. Furthermore,
18% stated that they had obtained information on the topic of
sexual motivated drug use from their family physician, on the
internet, or from friends. Only a few (3%) said they had contacted
an advice center (e.g., for advice on AIDS). One third (30%) had
previously received psychiatric or psychotherapeutic treatment;
the questionnaire did not ask about the reasons.
Just over half (54%; SD, 1.80; median, 1) of chemsex users
stated that they did not consider their sexually motivated
substance use to be a problem, and 6% strongly agreed with the
statement “I think my chemsex behavior is problematic.” Among
the chemsex users, 43% stated that they would not want to do
without chemsex in the future (SD, 1.90; median, 2), and 7%
strongly agreed with the statement “I would like to do without
chemsex in the future.”
DISCUSSION
In this study, one in three participants stated that they had
used illegal drugs in the past 12 months to influence their
sexual behavior. The group of chemsex users consisted mainly
of homosexual middle-aged men, most of whom were living
in a partnership. The majority had an average income and
were employed. Most used the 4 chems sporadically, but we
did not obtain information on the exact amount of use. The
average number of sexual partners, participation in group sex
sessions, and lack of protective measures against STDs indicate
that participants engaged in risky health behavior. The majority
of chemsex users were not aware of contact or advice centers
specializing in chemsex, and few of them had previously obtained
information or offers of help via public or private contact points.
Almost half of the chemsex users had moderate to significant
insight into the issues associated with their own chemsex
behavior, and almost a quarter of chemsex users had no desire
to refrain from chemsex in the future. Our findings indicate that
overall the chemsex user group has a positive sense of well-being.
The predominantly positive well-being can be explained on the
one hand by the mostly sporadic substance use and on the other
hand by demographic characteristics. Controlled and socially
ritualized substance use can reduce undesirable side effects, such
as overdoses (41), and therefore has a less negative influence on
well-being. Furthermore, this study used theWHO-5, which only
examines current well-being and does not record possible past
depressive phases. We can also assume that the study sample
had social support from a partner and a high socio-economic
status through their employment and salary, which in turn has
a positive influence on subjectively perceived well-being (42).
Findings on the participants’ insight into their own chemsex
behavior and the corresponding lack of a desire for change
indicate that they had only a low level of suffering. This might
be one explanation for the low number of participants who
had contacted contact points and advice centers on chemsex.
The findings can be further interpreted as showing that some
chemsex users are ambivalent about the thought of abstaining
from sexual motivated substance use. Noteworthy here is that
ambivalence should not be seen as an expression of resistance
toward counseling and treatment but as a starting point that
can be used to promote motivation and thus to improve one’s
own health behavior (43). Motivational interviewing may be
such a therapeutic starting point (44, 45). We can also assume
that chemsex users are a high-risk group with regard to sexual
and health behavior and that they are poorly informed about
options for advice on chemsex and treatment. This assumption is
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supported by the findings that chemsex users frequently changed
sexual partners and did not always protect themselves against
STDs or be tested for them. The low number of contacts with
contact and advice centers supports this assumption. Shame and
concern about stigma might act as barriers to seeking help and
support (46).
The study has some limitations that should be considered
when drawing possible conclusions. First, participants were
recruited specifically in the LGBTQ community and included
an above average number of MSM, especially in the group of
chemsex users which can be explained by the snowball sampling.
Second, although the WHO-5 has good psychometric properties
(39) it records self-reported, subjectively perceived well-being
over the past 2 weeks (40). This study did not consider other
aspects that may have influenced the well-being and thus mental
health of the participants, such as past trauma due to their
perceived and lived sexuality; 30% of chemsex users had received
psychiatric or psychotherapeutic treatment, so we can assume
that they had some kind of psychological stress. Third, this study
was an online survey, so it could not control for the conditions of
the participants. The participants’ responses may therefore have
been distorted because they were distracted or influenced by third
parties or because they provided incorrect information because
they want to give socially desirable responses. Limitations of
this study also include the aspect that biomarkers for the use of
clinical evaluation substances were not obtained in the process
of data collection. Fourth, IP addresses were not saved because
of data protection guidelines, so we cannot exclude that one
person answered the questionnaire several times. Last, a large
proportion of questionnaires were not completed, which may
be because the questions about sexual behavior and substance
use were perceived as being too intimate or the participants had
doubts about data protection.
CONCLUSIONS
Chemsex is becoming more widespread, so we need to
understand which interpersonal relationships and influences
exist in sexual motivated substance use, taking into account
the characteristics of users and their lives. The results of the
present study confirmed that chemsex is most common among
MSM, although other groups also practice it. In this sample,
chemsex users point out that they belong to a special risk
group due to lack of protection against sexually transmitted
infectious diseases, lack of education about chemsex and
little motivation to change. Future research should further
investigate the complexity of sexual orientation, sexual behavior,
drug use patterns, and motivation for chemsex. A uniform
definition of chemsex would improve comparability of studies,
and research on this topic would improve the knowledge
base. Additional studies on chemsex are urgently needed
because chemsex users are known to represent a high-risk
group that takes few precautions with regard to STDs and
because information on the topic and treatment options
are lacking.
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